Researchers Indicate That New Drug Shows Promise in Treating Mesothelioma
Mesothelioma cancer patients given pegargiminase had a 29% lower risk of death and 35% lower risk of disease progression in a recent clinical study.
Mesothelioma cancer patients given pegargiminase had a 29% lower risk of death and 35% lower risk of disease progression in a recent clinical study.
Lawsuit indicates that an Illinois woman suffered devastating injuries when a Bard PowerPort catheter fractured, causing small pieces to make their way into her heart.
Doctors struggled to remove the fractured chemo port from plaintiff's jugular vein, after a Bard PowerPort fragment pierced one of the chambers of her heart.
Pieces of the fractured Bard Infuse-A-Port remain in the plaintiffs heart, which puts her at risk of severe injuries in the future.
Manufacturer received reports of Bard PowerPort infections for years before plaintiff received her port catheter implant, but warnings were never provided to doctors and patients about the risks
Missouri woman indicates that the Bard PowerPort Clearvue failure rate is substantially higher than other port catheters, but information about the risk of complications was concealed by the manufacturer
Bard PowerPort fractured after it was implanted to administer breast cancer treatments, causing a 5-centimeter catheter piece to lodge in the plaintiff's heart, which will require additional surgeries to safely remove.
Chemotherapy drugs leaked after the port catheter ruptured, causing the plaintiff to suffer severe pain, burning and swelling from the harsh ingredients
Most rectal cancer patients who only received pre-surgical chemotherapy for locally advanced tumors were disease free after five years
Lawsuit alleges Taxotere caused epiphora in both eyes, joining a growing number of claims being pursued by former users of the chemotherapy drug left with debilitating watery eyes